Cited by 246Cholesterol and Lipid MetabolismCancer, Lipids, and MetabolismSphingolipid Metabolism and Signaling

Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism

Open access
Ferris, Heather A., Perry, Rachel J., Moreira, Gabriela V., Shulman, Gerald I., Horton, Jay D., Kahn, C. Ronald·2017·Proceedings of the National Academy of Sciences

Abstract

Significance: Cholesterol is important for normal brain function and it is believed that astrocytes produce most brain cholesterol. We have previously shown that diabetes results in decreased brain cholesterol synthesis by a reduction in the transcription factor sterol regulatory element-binding protein 2 (SREBP2). Using a mouse model in which SREBP2 has been knocked out in astrocytes, we show that astrocyte SREBP2 is required for normal brain development and behavior. Furthermore, this results in a shift in metabolism driven by increased brain glucose oxidation. Thus, SREBP2-mediated cholesterol synthesis in astrocytes plays an important role in brain development and function, and altered brain cholesterol synthesis may contribute to the interaction between diabetes and altered brain function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1620506114

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mice, astrocyte-specific loss of Srebf2 resulted in reduced cholesterol synthesis and defects in neurite outgrowth, behavior, and energy metabolism.

    “In mice, astrocyte-specific loss of Srebf2 resulted in reduced cholesterol synthesis and defects in neurite outgrowth, behavior, and energy metabolism (58).”

    From Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol (2023) · cites this paper as [58]

    The Discussion reports reduced astrocyte cholesterol synthesis and behavioral and metabolic changes in astrocyte-specific Srebf2 knockout mice. The neurite-outgrowth defect, however, was observed in an in-vitro coculture of mouse neurons with Srebf2-knockdown rat glioma cells, not in the knockout mice (SREBP2 in Astrocytes Is Required for Normal Neurite Outgrowth; page unavailable). (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Disruption of cholesterol biosynthesis in astrocytes alone directly impairs neurite outgrowth and synapse formation.

    “Previous work identified a direct impairment of neurite outgrowth and synapse formation when cholesterol biosynthesis was disrupted in astrocytes alone, further highlighting the importance of astrocyte health and function in the context of neurodevelopment (Ferris et al., 2017).”

    From Sterol dysregulation in Smith–Lemli–Opitz syndrome causes astrocyte immune reactivity through microglia crosstalk (2022) · cites this paper as Ferris et al., 2017

    The neurite-outgrowth section reports reduced neurite growth when neurons were cocultured with SREBP2-knockdown glial cells. The Discussion links astrocyte cholesterol loss to reduced synapse quality and quantity as an inference, but does not report a direct measurement of impaired synapse formation. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. Dietschy JM, Turley SD (2004) Thematic review series: Brain ipids. cholesterol me- tabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45(8):1375-1397.
  2. Balazs Z, et al. (2004) Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem 89(4):939-950.
  3. Schönfeld P, Reiser G (2013) Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab 33(10):1493-1499.
  4. Miao J, et al. (2014) Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins. J Lipid Res 55(4):659-667.
  5. Suzuki R, et al. (2010) Diabetes and insulin in regulation of brain cholesterol me- tabolism. Cell Metab 12(6):567-579.
  6. Suzuki R, Ferris HA, Chee MJ, Maratos-Flier E, Kahn CR (2013) Reduction of the cho- lesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function. PLoS Biol 11(4):e1001532.
  7. Fields RD, Woo DH, Basser PJ (2015) Glial regulation of the neuronal connectome through local and long-distant communication. Neuron 86(2):374-386.
  8. Volterra A, Liaudet N, Savtchouk I (2014) Astrocyte Ca 2+ signalling: An unexpected complexity. Nat Rev Neurosci 15(5):327-335.
  9. Mauch DH, et al. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294(5545):1354-1357.
  10. Barbero-Camps E, Fernández A, Martínez L, Fernández-Checa JC, Colell A (2013) APP/ PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pa- thology underlying Alzheimer's disease. Hum Mol Genet 22(17):3460-3476.
  11. Bajenaru ML, et al. (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol 22(14):5100-5113.
  12. Camargo N, et al. (2012) High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J 26(10):4302-4315.
  13. Morales-Corraliza J, et al. (2013) Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model. Neurobiol Aging 34(1):137-145.
  14. Pistell PJ, Ingram DK (2010) Development of a water-escape motivated version of the Stone T-maze for mice. Neuroscience 166(1):61-72.
  15. Morrison SF, Madden CJ (2014) Central nervous system regulation of brown adipose tissue. Compr Physiol 4(4):1677-1713.
  16. Coelho-Aguiar JdeM, et al. (2015) The enteric glia: Identity and functions. Glia 63(6): 921-935.
  17. Waniewski RA, Martin DL (1998) Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18(14):5225-5233.
  18. Kleinridders A, Ferris HA, Cai W, Kahn CR (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63(7):2232-2243.
  19. Talbot K, et al. (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122(4):1316-1338.
  20. Schubert M, et al. (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101(9):3100-3105.
  21. Bomfim TR, et al. (2012) An anti-diabetes agent protects the mouse brain from de- fective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J Clin Invest 122(4):1339-1353.
  22. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS (2012) Overview and findings from the religious orders study. Curr Alzheimer Res 9(6):628-645.
  23. Bennett DA, et al. (2012) Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 9(6):646-663.
  24. Craft S, et al. (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol 69(1):29-38.
  25. Claxton A, et al. (2013) Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alz- heimer's disease. J Alzheimers Dis 35(4):789-797.
  26. Fukui K, Ferris HA, Kahn CR (2015) Effect of cholesterol reduction on receptor sig- naling in neurons. J Biol Chem 290(44):26383-26392.
  27. Fox TE, et al. (2011) Insulin signaling in retinal neurons is regulated within cholesterol- enriched membrane microdomains. Am J Physiol Endocrinol Metab 300(3):E600-E609.
  28. Craft S, et al. (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer's dis- ease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology 50(1):164-168.
  29. Camporez JP, et al. (2013) Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin re- sistance. Endocrinology 154(3):1021-1028.
  30. Perry RJ, et al. (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160(4):745-758.
  31. Shimano H, et al. (1996) Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98(7):1575-1584.
  32. Zhuo L, et al. (1997) Live astrocytes visualized by green fluorescent protein in trans- genic mice. Dev Biol 187(1):36-42.
  33. Brooks SP, Dunnett SB (2009) Test to assess motor phenotype in mice: A user's guide. Nat Rev Neurosci 10(7):519-529.
  34. Petersen KF, et al. (2015) Effect of aging on muscle mitochondrial substrate utilization in humans. Proc Natl Acad Sci USA 112(36):11330-11334.

Cited by

Sorted by citations

Authors
Ferris, H. A., Perry, R. J., Moreira, G. V., Shulman, G. I., Horton, J. D., & Kahn, C. R.
Affiliations
  • Joslin Diabetes Center (US)
  • Yale University (US)
  • Howard Hughes Medical Institute (US)
  • The University of Texas Southwestern Medical Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2017-01-17
Volume
114
Issue
5
Pages
1189-1194
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2579178448
Cited by
246
References
43
Citations by year
2026: 26 · 2025: 38 · 2024: 34 · 2023: 37 · 2022: 29 · 2021: 25 · 2020: 29 · 2019: 19 · 2018: 5 · 2017: 4
FWCI
15.97
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (5K08DK097293, R01 DK-40936, MMPC DK059635, R37DK031036)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
SREBP2, brain cholesterol, astrocyte-neuron co-culture, neurite outgrowth, brain development, motor defects, energy balance, body composition, glucose oxidation, brain metabolism, diabetes mellitus, metabolic disorders
MeSH terms
Animals, Astrocytes, Body Composition, Brain, Cholesterol, Energy Metabolism, Female, Glioma, Glucose, Hyperinsulinism, Male, Mice, Inbred C57BL, Neoplasm Proteins, Nesting Behavior, Oxidation-Reduction, Neurites, Mice, Knockout, Maze Learning, Rotarod Performance Test, Cell Line, Tumor, Mice, Rats, Sterol Regulatory Element Binding Proteins, Sterol Regulatory Element Binding Protein 2, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review